FTC Intervenes in Teva Pharmaceutical Industries’ Proposed $8.9 Billion Acquisition of Barr Pharmaceuticals

Teva Pharmaceuticals Industries Ltd.’s has settled Federal Trade Commission charges that its proposed $8.9 billion acquisition of rival generic drugmaker…

15 years ago

FTC Settles Charges with Telemarketers Who Duped Elderly Consumers

At the request of the Federal Trade Commission, a federal district court has entered orders settling charges against three telemarketers…

15 years ago

Subprime Credit Card Marketer to Provide At Least $114 Million in Consumer Redress to Settle FTC Charges of Deceptive Conduct

CompuCredit Corporation, a company marketing Visa and MasterCard credit cards to consumers in the subprime credit market, has agreed to…

15 years ago

Subprime Credit Card Marketer to Provide At Least $114 Million in Consumer Redress to Settle FTC Charges of Deceptive Conduct

CompuCredit Corporation, a company marketing Visa and MasterCard credit cards to consumers in the subprime credit market, has agreed to…

15 years ago

FTC Issues Report on Social Security Numbers and Identity Theft

The Federal Trade Commission issued a report today recommending five measures to help prevent Social Security numbers from being used…

15 years ago

FTC Issues Report on Social Security Numbers and Identity Theft

The Federal Trade Commission issued a report today recommending five measures to help prevent Social Security numbers from being used…

15 years ago

Commission Approves Final Consent Order in Matter of Premier Capital Lending, Inc.

Following a public comment period, the Commission has approved a final consent order in the matter of Premier Capital Lending,…

15 years ago

FTC Sues Ovation Pharmaceuticals for Illegally Acquiring Drug Used to Treat Premature Babies with Life-Threatening Heart Condition

The Federal Trade Commission today filed a complaint in federal district court challenging Ovation Pharmaceuticals, Inc.’s January 2006 acquisition of…

15 years ago

FTC Sues Ovation Pharmaceuticals for Illegally Acquiring Drug Used to Treat Premature Babies with Life-Threatening Heart Condition

The Federal Trade Commission today filed a complaint in federal district court challenging Ovation Pharmaceuticals, Inc.’s January 2006 acquisition of…

15 years ago

Policy Planning Director Maureen Ohlhausen To Leave FTC; James Cooper Named Acting Director

Federal Trade Commission Chairman William E. Kovacic announced today that Maureen Ohlhausen, Director of the agency’s Office of Policy Planning…

15 years ago